RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (4)
Comprehensive strategy for capturing and integrating community input into community research training curricula.
Differences in Weight Loss by Race and Ethnicity in the PRIDE Trial: a Qualitative Analysis of Participant Perspectives.
Population-Based Frequency of Ophthalmic Adverse Events in Melanoma, Other Cancers, and After Immune Checkpoint Inhibitor Treatment.
Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status.
Keung MY, Wu Y, Badar F, Vadgama JV. Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status. J Clin Med. 2020 Mar 30; 9(4).
View in:
PubMed
authors with profiles
Jaydutt V Vadgama, PhD
Yanyuan Wu, MD